australianprescriber.tg.org.au Open in urlscan Pro
13.107.213.31  Public Scan

Form analysis
2 forms found in the DOM

Name: searchForm — javascript:void(0)

<form id="searchForm" onsubmit="return searchAction()" name="searchForm" action="javascript:void(0)" enctype="multipart/form-data" accept-charset="UTF-8">
  <div class="input-group search-widget search">
    <div class="form-group">
      <input type="text" id="searchString" class="form-control" placeholder="Search" autocomplete="off">
    </div>
    <span id="searchBtn" onclick="searchAction()" style="cursor: pointer" class="input-group-btn fa fa-search"><a class="" onclick="submitform()"></a></span>
  </div>
</form>

<form inert="" class="_hj-hRovs__styles__form">
  <div class="_hj-c8PC+__styles__surveyBody" style="min-height: 82px;">
    <div aria-live="off" class="_hj-S9XKO__styles__surveyTitle   " id="hj-survey-lbl-1" aria-label="Did you find this page useful?">Did you find this page useful?</div>
    <div class="_hj-E2-N0__styles__surveyAnswers">
      <div aria-labelledby="hj-survey-lbl-1" class="" role="radiogroup">
        <div class="_hj-A3HLw__styles__closeEndedOption"><label style="color: rgb(17, 17, 17) !important;"><input type="radio" class="_hj-uHHqX__styles__closeEndedOptionInput"><span
              class="_hj-xtIh3__styles__closeEndedOptionIcon _hj-S4Tmx__styles__radio _hj-sHuYH__styles__light"></span><span class="_hj-InliL__styles__closeEndedOptionText" style="color: rgb(17, 17, 17) !important;">Yes</span></label></div>
        <div class="_hj-A3HLw__styles__closeEndedOption"><label style="color: rgb(17, 17, 17) !important;"><input type="radio" class="_hj-uHHqX__styles__closeEndedOptionInput"><span
              class="_hj-xtIh3__styles__closeEndedOptionIcon _hj-S4Tmx__styles__radio _hj-sHuYH__styles__light"></span><span class="_hj-InliL__styles__closeEndedOptionText" style="color: rgb(17, 17, 17) !important;">No</span></label></div>
      </div>
    </div>
  </div>
  <div class="_hj-XpAaA__styles__surveyFooter">
    <div class="_hj-8Lgv6__styles__surveyActions"><button type="button" disabled="" class="_hj-81Zzt__styles__surveyActionButton _hj-O-7CS__styles__surveysPrimaryButton _hj-SU8LU__styles__primaryButton">Next</button></div>
    <div class="_hj-PZjqr__styles__surveyBranding">
      <a rel="noopener noreferrer" target="_blank" href="https://www.hotjar.com/feedback-surveys?utm_source=client&amp;utm_medium=poll&amp;utm_campaign=insights" class="_hj-fBs9+__styles__link" style="color: rgb(50, 50, 50) !important;"><img alt="Hotjar — Surveys page" class="_hj-KMFsk__styles__logo" src="data:image/svg+xml,%0A%3Csvg width='17' height='20' viewBox='0 0 17 20' fill='none' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='M6.68018 8.34533C8.7842 7.17645 11.6658 5.57522 11.6658 0.91507H8.17653C8.17653 3.52244 6.90715 4.22763 4.98564 5.29517C2.88163 6.46448 0 8.065 0 12.7256H3.48929C3.48929 10.1181 4.75867 9.41287 6.68018 8.34533Z' fill='%23FF3200'/%3E%3Cpath d='M12.7195 7.27443C12.7195 9.88194 11.4501 10.5871 9.52861 11.6545C7.42516 12.8234 4.54297 14.4244 4.54297 19.0849H8.03212C8.03212 16.4774 9.3015 15.7722 11.223 14.7047C13.327 13.5358 16.2085 11.935 16.2085 7.27443H12.7195Z' fill='%23FF3200'/%3E%3C/svg%3E%0A"><div class="_hj-ex4tC__styles__brandingText"><span style="text-decoration: underline;">Made with Hotjar</span></div></a>
    </div>
  </div>
</form>

Text Content

Skip to main content
 
   
 * The organisation 
   * The organisation
   * 
   * Governance
   * Board of directors
   * Expert groups
   * Members of Company
   * History
   * History Timeline
   * Careers
   * Guideline development
   * Partnership program
   * Research funding
 * News
   
   
   
 * Products 
   * Therapeutic Guidelines
   * Australian Prescriber
   * Books
   * Antibiotic prescribing in primary care: summary table
 * Updates
 * Contact us


 * Menu


 * Home
 * The organisation
 * News
 * Products
 * Updates
 * Contact us

 * Home

 * A
 * A

 * All Issues
 * Podcasts
 * 


AUSTRALIAN PRESCRIBER

Australian Prescriber is an independent peer-reviewed journal providing critical
commentary on drugs and therapeutics for health professionals.


SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Free subscriptions for Australian Prescriber are available through Therapeutic
Guidelines.

Subscribe now


 * VOLUME 47 ISSUE 1

 * February 2024

 * Download PDF
 * Share
    * 
      Email
    * 
      Facebook
    * 
      Twitter
    * 
      LinkedIn


MANAGING PRE-EXISTING DIABETES PRIOR TO AND DURING PREGNANCY

Article
Leonie K Callaway, Fiona Britten
 * 20 February 2024

Women with pre-existing diabetes who are planning pregnancy benefit most from
specialist care before conceiving, to optimise their glycaemic management and
general health.

Article


MANAGING HYPERCHOLESTEROLAEMIA

Article


MANAGING HYPERCHOLESTEROLAEMIA

Adam J Nelson, Stephen J Nicholls
 * 20 February 2024
 * 

Which lipids have the strongest causal links to atherosclerotic cardiovascular
disease? Find out who requires lipid-lowering therapy and what interventions can
have the greatest effect on LDL-C concentration.

Article


THERAPEUTIC INERTIA

Article


THERAPEUTIC INERTIA

Tim Usherwood
 * 20 February 2024

There are a range of strategies that clinicians and patients can use to minimise
therapeutic inertia and improve chronic disease management. Undertreatment due
to therapeutic inertia is a significant contributor to suboptimal control in
many chronic conditions.

Article


DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC OESOPHAGITIS

Article


DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC OESOPHAGITIS

Varan Perananthan, Rebecca Burgell
 * 20 February 2024

Eosinophilic oesophagitis is related to food allergy and presents with dysphagia
and food bolus impaction. A new orally disintegrating tablet formulation of
budesonide provides a useful alternative to dietary intervention.

Medicinal mishap


SEVERE LIVER INJURY FOLLOWING USE OF RAD-140, A SELECTIVE ANDROGEN RECEPTOR
MODULATOR, FOR BODY BUILDING

Medicinal mishap


SEVERE LIVER INJURY FOLLOWING USE OF RAD-140, A SELECTIVE ANDROGEN RECEPTOR
MODULATOR, FOR BODY BUILDING

Varan Perananthan, Jacob George
 * 20 February 2024

The selective androgen receptor modulator, RAD-140, used by body builders, can
cause severe idiosyncratic hepatotoxicity.

Latest news


TGA MEDICINES SAFETY UPDATE AND AUSTRALIAN PRESCRIBER—BACK TO THE FUTURE (TAKE
2)

Latest news


TGA MEDICINES SAFETY UPDATE AND AUSTRALIAN PRESCRIBER—BACK TO THE FUTURE (TAKE
2)

 * 20 February 2024

Summaries of Medicines Safety Updates published by the TGA will now be shared on
the Australian Prescriber website to increase the reach of these important
messages.

Latest news


MORPHINE ORAL LIQUID AVAILABILITY

Latest news


MORPHINE ORAL LIQUID AVAILABILITY

 * 20 February 2024

The only registered morphine oral liquid product in Australia has now been
discontinued. The TGA has enabled access to alternative products through section
19A of the Therapeutic Goods Act 1989.


NEW DRUGS


New drug


ANDEXANET ALFA FOR REVERSAL OF DIRECT FACTOR XA INHIBITOR ANTICOAGULATION

New drug


ANDEXANET ALFA FOR REVERSAL OF DIRECT FACTOR XA INHIBITOR ANTICOAGULATION

 * 20 February 2024

Andexanet alfa is designed to neutralise the anticoagulant effect of direct
factor Xa inhibitors, such as apixaban and rivaroxaban.


TGA MEDICINES SAFETY UPDATE SUMMARY


TGA Medicines Safety Update summary


USE CAUTION WHEN PRESCRIBING BACLOFEN OFF LABEL

TGA Medicines Safety Update summary


USE CAUTION WHEN PRESCRIBING BACLOFEN OFF LABEL

 * 20 February 2024


TGA Medicines Safety Update summary


NEW WARNINGS OF ROMOSOZUMAB (EVENITY) CARDIOVASCULAR RISKS

TGA Medicines Safety Update summary


NEW WARNINGS OF ROMOSOZUMAB (EVENITY) CARDIOVASCULAR RISKS

 * 20 February 2024




SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Free subscriptions for Australian Prescriber are available through Therapeutic
Guidelines.

Subscribe now


 * 
 * Follow Australian Prescriber on Twitter @AustPrescriber

 * 
 * 
 * 

 * About Australian Prescriber
 * Contact us


DATE PUBLISHED: 20 FEBRUARY 2024


FOOTER

 * Conditions of use and disclaimer
 * Privacy policy
 * Licence agreement
 * Copyright permission
 * Support and FAQ

© 2024 Therapeutic Guidelines Limited. All rights reserved.
ABN 45 074 766 224

Feedback
Did you find this page useful?
Yes
No
Next
Made with Hotjar